Accenture Accelerated R&D Services
- Accenture enhances drug development from discovery to approval with launch of Accenture Accelerated R&D Services. Company investing more than $200 million to help clients modernize R&D and accelerate new products to market through the combination of cloud computing, mobility and analytics.
- Accenture completed the acquisition of Octagon on September 26, 2012. Over the coming months the Octagon team and services will become a fully integrated addition to Accenture’s Life Sciences industry group. To read what top industry analysts are saying about the acquisition, please click here.
No webinars currently scheduled - please check back frequently for updates